Bank Of New York Mellon Corp Rvl Pharmaceuticals PLC Transaction History

Bank Of New York Mellon Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.02 - $1.61 $12,319 - $19,445	12,078 New	12,078 $13,000
Q2 2021 Aug 11, 2021	SELL	$2.8 - $3.78 $96,510 - $130,289	-34,468 Reduced 74.05%	12,078 $36,000
Q1 2021 May 13, 2021	SELL	$3.26 - $4.84 $3,054 - $4,535	-937 Reduced 1.97%	46,546 $151,000
Q4 2020 Feb 09, 2021	BUY	$4.12 - $6.29 $25,725 - $39,274	6,244 Added 15.14%	47,483 $195,000
Q3 2020 Nov 12, 2020	BUY	$4.82 - $8.77 $60,717 - $110,475	12,597 Added 43.98%	41,239 $223,000
Q2 2020 Aug 12, 2020	BUY	$2.83 - $6.99 $17,862 - $44,120	6,312 Added 28.27%	28,642 $192,000
Q1 2020 May 06, 2020	BUY	$3.18 - $7.0 $1,097 - $2,415	345 Added 1.57%	22,330 $71,000
Q3 2019 Nov 07, 2019	BUY	$2.8 - $3.99 $27,552 - $39,261	9,840 Added 81.02%	21,985 $84,000
Q2 2019 Aug 12, 2019	SELL	$2.34 - $4.28 $25,653 - $46,921	-10,963 Reduced 47.44%	12,145 $46,000
Q1 2019 May 14, 2019	BUY	$3.6 - $8.75 $83,188 - $202,195	23,108 New	23,108 $83,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.